# Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated

> **NCT00869713** · PHASE2 · COMPLETED · sponsor: **U.S. Army Medical Research and Development Command** · enrollment: 98 (actual)

## Conditions studied

- Rift Valley Fever

## Interventions

- **BIOLOGICAL:** Inactivated, Dried (TSI-GSD 200), RVF Vaccine

## Key facts

- **NCT ID:** NCT00869713
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2019-02
- **Final completion:** 2021-05
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2022-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00869713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00869713, "Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00869713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*